Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00131365 · ClinicalTrials.gov registry record · NA
Magnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine Fibroids
A NA study, sponsored by InSightec.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT00131365: Completed NA study, sponsored by InSightec.
NCT00131365 is a NA study that has completed, run by InSightec. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00131365, a NA study, has completed, sponsored by InSightec.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The goal of this study is to develop additional long term data to evaluate the safety and effectiveness of this treatment. Indications for use for this system is: 'The ExAblate is intended to ablate uterine fibroid tissue in pre- or peri-menopausal women with symptomatic uterine fibroids who desire a uterine sparing procedure. Patients must have a uterine size of less than 24 weeks and not seeking treatment for reasons of improving fertility.'
Primary Outcome
Adverse events outcomes are reported in the adverse events module.
Interventions
- DEVICE ExAblate 2000
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2006-01 |
| Est. Completion | 2009-02 |
| Phase | NA |
What the finished NCT00131365 record still lists
NCT00131365 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which ExAblate 2000 is the first listed.
NCT00131365 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00131365 about?
NCT00131365 is a clinical study titled "Magnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine Fibroids". The goal of this study is to develop additional long term data to evaluate the safety and effectiveness of this treatment. Indications for use for this system is: 'The ExAblate is intended to ablate uterine fibroid tissue in pre- or peri-menopausal women with symptomatic uterine fibroids who desire...
What is the current status of trial NCT00131365?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2006-01. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00131365?
The interventions under investigation include: ExAblate 2000 (DEVICE).
Who is sponsoring clinical trial NCT00131365?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00131365's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia